ARCHIVES

FDA Hazleton Probe Finds Some Problems; Results Unaffected

This article is from The Cancer Letter archive.

Vol. 02 No. 17 | April 23, 1976

Download PDF Visit The Full Archive

Related Articles

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Advocacy: Journal Club Leader Sought By NBCC

August 22, 1997

Dose Adjustments Of Other Drugs Questioned; Underdosing Or Overdosing?

October 15, 2010

Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds

December 26, 2008

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Fy 1981 Budget Breakdown B Mechanism, Activity

February 1, 1980